Else Nutrition Holdings Inc experienced a staggering 25% drop in its stock price today, raising concerns among investors.
In the latest trading session, Else Nutrition Holdings Inc (BABY.TO) saw its stock price plummet by 25%, closing at just CA$0.01. This significant decline has left investors questioning the company's stability and future prospects.
Investor takeaway: The sharp drop in Else Nutrition's stock price highlights the volatility and risks associated with investing in emerging companies, especially those in the competitive nutrition sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Else Nutrition Holdings Inc
BABY.TO
BABY.TO
Else Nutrition Holdings Inc
WealthAwesomeMarket cap
$1.15M
52W high
$0.25
52W low
$0.01
1W change
+0.00%
Beta
0.97
Analyst Price Targets
Based on analyst covering BABY
Wall Street analysts forecast BABY stock price to rise 24900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.00
+24900.0% Upside
Current Price
C$0.02
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BABY's historical volatility
30-Day Vol
183.7%
Annualized
90-Day Vol
178.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.04 |
| 90 trading days | C$0.02 | C$0.01 – C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
25% Drop in Stock Price
Else Nutrition Holdings Inc's market cap now stands at CA$862,343, reflecting investor concerns over its financial viability.
Bull case
Despite today’s downturn, Else Nutrition has shown promise in the past. The company has made operational progress and is expanding its market presence, which could lead to recovery if managed well.
Bear case
However, the recent decline raises serious questions about the company’s financial health and its ability to handle market challenges. With a negative profit margin and no dividends, investors are right to be cautious.
Advertisement
